Phase I trial with the CD44v6-targeting immunoconjugate bivatuzumab mertansine in head and neck squamous cell carcinoma (Q46802272)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Phase I trial with the CD44v6-targeting immunoconjugate bivatuzumab mertansine in head and neck squamous cell carcinoma |
scientific article |
Statements
1 reference
Phase I trial with the CD44v6-targeting immunoconjugate bivatuzumab mertansine in head and neck squamous cell carcinoma (English)
1 reference
Herbert Riechelmann
1 reference
Alexander Sauter
1 reference
Wolfram Golze
1 reference
Gertraud Hanft
1 reference
Carsten Schroen
1 reference
Karl Hoermann
1 reference
Thomas Erhardt
1 reference
Silke Gronau
1 reference
18 January 2008
1 reference
1 reference
44
1 reference
9
1 reference
823-829
1 reference